ALPHA TEKNOVA, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent
ALPHA TEKNOVA, INC. (TKNO) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent of 0.10% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2025-03-07
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2024 was 0.10%, a 85.71% decline from fiscal 2023.
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2023 was 0.70%, a 250.00% increase from fiscal 2022.
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2022 was 0.20%, a 66.67% decline from fiscal 2021.
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2021 was 0.60%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month |
|---|---|
| 2024-12-31 | 0.10% 10-K · filed 2025-03-07 |
| 2023-12-31 | 0.70% 10-K · filed 2025-03-07 |
| 2022-12-31 | 0.20% 10-K · filed 2024-03-27 |
| 2021-12-31 | 0.60% 10-K · filed 2023-03-30 |
| 2020-12-31 | 0.00% 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |